News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
CHEPLAPHARM reorganises Management Team
CHEPLAPHARM reorganises Management Team with new appointments and expanded responsibilities, preparing for the future. Artem Gevorkyan joins as Managing Director Corporate Business Development, Karl Lang leads Supply Chain & Logistics, Klaus Köhl leaves company -
-
-
COMMUNIQUÉ DE PRESSE
CHEPLAPHARM closes financial year 2023 with record revenue and double-digit growth
CHEPLAPHARM reports record revenue of €1.5 billion and 17% year-over-year growth in financial year 2023. EBITDA up 14% to €780.5 million with stable 52% margin. Expansion with new affiliates in Japan and Switzerland -
